Hypertrophic cardiomyopathy trials in Austria

In Austria 6 Also abroad 88

6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy
Where
Graz
Age
18 years and over
People
130 worldwide
Run by
Imbria Pharmaceuticals Inc.
See details and how to join2024-515125-28-00 · EU 2024-515125-28-00
Phase 2Taking people
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Where
Graz
Age
18 years and over
People
165 worldwide
Run by
Imbria Pharmaceuticals, Inc.
See details and how to joinNCT07023614
No phaseTaking people
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Where
Braunau am Inn, Graz, Innsbruck, Klagenfurt, Linz, Sankt Pölten, Vienna
Age
18 years and over
People
1,700 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT05489705
Phase 4Taking people
HYDrochlorothiazidE compared to valsartan to treat arterial hypertension in patients with Hypertrophic obstructive CardioMyopathy – the HYDE-HCM Trial
Where
Graz, Linz, St. Pölten, Vienna, Wien
Age
18 years and over
People
40
Run by
Medical University Of Graz
See details and how to join2024-520086-31-00 · EU 2024-520086-31-00
No phaseTaking people
Austrian Hypertrophic Cardiomyopathy Registry
Where
Braunau am Inn, Graz, Innsbruck, Linz, Salzburg, Sankt Johann in Tirol, Sankt Pölten, Schwarzach im Pongau, Vienna, Wels-Grieskirchen, Wiener Neustadt
Age
18 years and over
People
1,000
Run by
Medical University of Graz
See details and how to joinNCT06368518
No phaseTaking people
Myocardial Perfusion Changes Following Optimal Medical Treatment in Symptomatic Hypertrophic Cardiomyopathy
Where
Vienna
Age
18 years and over
People
20
Run by
Medical University of Vienna
See details and how to joinNCT07150299